VOR Vor Biopharma Inc.
Executive Summary
Five mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) collectively more than doubled their VOR positions in Q4 2025, adding $31.8M in new holdings to reach $50.8M total. This is an index-driven rebalancing move, likely reflecting VOR's continued inclusion in growth/small-cap passive mandates, not an active conviction thesis. The net 11% win rate on prior VOR reports at T+20 and negative historical calibration for this segment caution against over-weighting the signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: $31.8M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Vanguard | DOUBLED | +632.2% | $10.1M | $5.0M |
| BlackRock | DOUBLED | +1248.5% | $6.1M | $4.4M |
| State Street | DOUBLED | +905.7% | $1.2M | $750.0K |
| Fidelity | DOUBLED | +968.1% | $33.0M | $21.5M |
| Morgan Stanley | DOUBLED | +538.8% | $372.0K | $155.0K |
Actionable Insight
The buying is entirely mega-passive, reflecting index rebalancing rather than active conviction. Monitor for active fund interest (e.g., healthcare-specialist hedge funds or biotech-focused funds) as a stronger signal. The historical T+20 drift for VOR reports is negative on balance, suggesting fading this passive accumulation is the higher-probability trade near term.
Key Facts
- 5 institutions accumulated $31.8M net in VOR during Q4 2025, bringing aggregate holdings to $50.8M
- Every buyer was a mega-passive fund: Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley
- All five funds DOUBLED or more their positions (range: +539% to +1249% share increases)
- Zero institutional sellers detected in this cluster
- Prior VOR reports have a T+20 win rate of only 11%, with historical net alpha of -2.1% T+20 in this filing segment
Financial Impact
5 institutions accumulated $31.8M in new VOR holdings, increasing total disclosed institutional position value from $19.0M to $50.8M
Risk Factors
- No active or catalyst-driven buyers — all accumulation is passive/index rebalancing, which carries weaker predictive signal
- 13F data is stale (45-day lag); positions may have already been unwound or adjusted
- Historical calibration shows negative expected alpha at T+20 for this filing segment
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-VOR-2025-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
2d ago
|
Institutional Cluster
| $13.00 awaiting T+20 | awaiting T+20 | — | — |
|
Jun 8, 2026
5d ago
|
Press Release
| $13.10 awaiting T+20 | awaiting T+20 | — | — |
|
May 7, 2026
5w ago
|
EFFECT
| $16.08 $13.44 | ▼ −16.42% | ▼ −19.55% | — |
|
Apr 27, 2026
6w ago
|
S-3
| $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | — |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | — |
|
Mar 27, 2026
11w ago
|
Press Release
| $14.48 $14.12 | ▼ −2.49% | ▼ −15.23% | — |
|
Mar 23, 2026
11w ago
|
Press Release
| $12.15 $15.32 | ▲ +26.09% | ▲ +17.19% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access